Meningitis, Public Health | featured news

The U.S. Food and Drug Administration took 684 days to issue a warning letter after uncovering serious issues at the pharmacy at the center of the deadly U.S. meningitis outbreak, newly released documents showed.

It was just an e-mail about a single case of illness, but a gut instinct developed through years of disease detective work made Dr. Marion Kainer sense a bigger danger. Kainer, the director of health care-associated infections for the Tennessee Department of Health, started investigating the day she got that e-mail and hasn't stopped since. She camped out in her office for three weeks, leading a team of state workers as they traced the source of what would become a national outbreak of fungal meningitis.

Vilinda York lies in her Florida hospital bed, facing a dry-erase board that lists in green marker her name, her four doctors and a smiley face. Also on the board is this: "Anticipated date of discharge: NOT YET DETERMINED."

Executives at the Boston-area pharmacy whose steroid shots have been linked to a deadly U.S. meningitis outbreak have been sued in a bid to freeze their personal assets, while the death toll in the scandal rose to 21, with 268 cases of infection reported.

The House of Representatives on Friday widened its investigation into the deadly meningitis outbreak to include the role health regulators played in monitoring the pharmacy that produced steroid treatments suspected of causing the crisis.

The number of people infected with a rare type of meningitis tied to contaminated steroid injections has climbed to 105, federal health officials said Monday.

As authorities continue to focus on a potentially contaminated steroid as the source of a widening outbreak of fungal meningitis, some patient-safety advocates are calling for greater restrictions on the type of injection involved.

An outbreak of a rare form of meningitis is likely to grow after sickening 26 people in five states, including four who died, health officials warned... All received steroid injections used mostly for back pain that have been traced back to a specialty pharmacy in Massachusetts. The pharmacy issued a recall last week and has shut down operations.